DUBLIN, Dec 21, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Clinical Trial Imaging Market - Global Forecast to 2021" report to their offering.
The global clinical trial imaging market is projected to reach USD 1069.7 Million by 2021 from USD 773.4 Million in 2016, at a CAGR of 6.7% from 2016 to 2021.In this report, the global market is broadly segmented by product and service, modality, end user, and region.
Major factors fueling market growth are the increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the market. On the other hand, the high implementation cost of imaging systems is restraining the growth of this market.
On the basis of product and service, the market is segmented into service and software. The service segment is expected to account for the largest share of the market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.
Furthermore, On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities (such as magnetic resonance elastography (MRE) and dual-energy X-ray absorptiometry (DXA)). In 2016, the CT segment is expected to account for the largest share of the global market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body.
On the basis of end user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users (cosmetics and skin care companies). Pharmaceutical companies are expected to account for the largest share of the global market in 2016. Increased R&D budgets of pharmaceutical companies is the primary growth driver for this end-user segment.
- Bioclinica, Inc.
- Biomedical Systems Corporation
- Biotelemetry, Inc.
- Cardiovascular Imaging Technologies, LLC
- Icon PLC
- Intrinsic Imaging LLC
- Ixico PLC
- Parexel International Corporation
- Radiant Sage LLC
- Worldcare Clinical, LL
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Clinical Trial Imaging Market, by Product and Service
7 Clinical Trial Imaging Market, by Modality
8 Clinical Trial Imaging Market, by End User
9 Clinical Trial Imaging Market, by Region
10 Competitive Landscape
11 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/33t7wg/clinical_trial
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clinical-trial-imaging-market---by-product--services-modality--end-user---global-forecast-to-2021---research-and-markets-300382389.html
SOURCE Research and Markets